Model to Predict Node Negative Disease After Neoadjuvant Chemotherapy Using Data from the National Cancer Data Base

被引：0
|
作者：
Murphy, B. L. [1 ]
Hoskin, T. [1 ]
Day, C. [1 ]
Habermann, E. B. [1 ]
Boughey, J. C. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2017年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PT36
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [1] Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy: A Report From the National Cancer Data Base
    Kantor, Olga
    Liederbach, Erik
    Wang, Chi-Hsiung
    Winchester, David J.
    Pesce, Catherine
    Yao, Katharine
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : 64 - 65
  • [2] Development of a model to predict breast cancer survival using data from the National Cancer Data Base
    Garg, A. K.
    BREAST DISEASES, 2016, 27 (02): : 118 - 120
  • [3] Development of a model to predict breast cancer survival using data from the National Cancer Data Base
    Asare, Elliot A.
    Liu, Lei
    Hess, Kenneth R.
    Gordon, Elisa J.
    Paruch, Jennifer L.
    Pails, Bryan
    Dahlke, Allison R.
    McCabe, Ryan
    Cohen, Mark E.
    Winchester, David P.
    Bilimoria, Karl Y.
    SURGERY, 2016, 159 (02) : 495 - 502
  • [4] Neoadjuvant Chemotherapy for Metaplastic Breast Cancer: A National Cancer Data Base Review
    Dinh, K. H.
    Diego, E. J.
    Steiman, J. G.
    Soran, A.
    Keenan, D.
    Johnson, R.
    McAuliffe, P. F.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S100 - S101
  • [5] National Trends in the Use of Neoadjuvant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study
    Carlos A. Puig
    Tanya L. Hoskin
    Courtney N. Day
    Elizabeth B. Habermann
    Judy C. Boughey
    Annals of Surgical Oncology, 2017, 24 : 1242 - 1250
  • [6] National Trends in the Use of Neoadjuvant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study
    Puig, Carlos A.
    Hoskin, Tanya L.
    Day, Courtney N.
    Habermann, Elizabeth B.
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (05) : 1242 - 1250
  • [7] Trends in Neoadjuvant Chemotherapy Utilization in Triple Negative Breast Cancer and Effect on Surgical Procedure in the National Cancer Data Base
    Voci, Amy
    Sarma, Deba
    Hadzikadic-Gusic, Lejla
    Han, Yimei
    Perry, I'sis
    Sarantou, Terry
    Forster, Meghan R.
    Tan, Antoinette
    White, Richard L., Jr.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) : E7 - E7
  • [8] Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base
    Killelea, Brigid K.
    Yang, Vicky Q.
    Wang, Shi-Yi
    Hayse, Brandon
    Mougalian, Sarah
    Horowitz, Nina R.
    Chagpar, Anees B.
    Pusztai, Lajos
    Lannin, Donald R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (36) : 4267 - +
  • [9] National Trends in the Use of Neoadjuvant Chemotherapy and Impact on Breast and Axillary Surgery in Hormone Receptor Negative Breast Cancer: A National Cancer Data Base Study
    Puig, C. A.
    Hoskin, T. L.
    Heins, C. N.
    Boughey, J. C.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S13 - S14
  • [10] Does Race Play a Role in Breast-Conserving Surgery After Neoadjuvant Chemotherapy? Results from the National Cancer Data Base
    Enomoto, L. M.
    Clark, C.
    Chiba, A.
    Levine, E.
    Howard-McNatt, M.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S68 - S68
12345